Pharmaceutical companies join forces on HIV

Declan Butler

Nature, 2009, vol. 458, issue 7241, 950-951

Abstract: GlaxoSmithKline and Pfizer create spin-off to develop new combination drugs.

Date: 2009
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/458950b Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:458:y:2009:i:7241:d:10.1038_458950b

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/458950b

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().